DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
A logo

Agilent Technologies, Inc. Stock Price

NYSE:A Community·US$41.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 58 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

A Share Price Performance

US$144.75
20.63 (16.62%)
​
US$174.90
Fair Value
US$144.75
20.63 (16.62%)
17.2% undervalued intrinsic discount
US$174.90
Fair Value
Price US$144.75
AnalystConsensusTarget US$174.90
Thu, 3 Sep 26
Fair ValueUS$174.90
Share Pricen/a

A Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$174.9 17.2% undervalued intrinsic discount

A: Global Healthcare Trends And New Diagnostic Solutions Will Shape Future Performance

0users have liked this narrative
0users have commented on this narrative
32users have followed this narrative
A logo
Agilent Technologies
17.2% undervalued intrinsic discount

A: Global Healthcare Trends And New Diagnostic Solutions Will Shape Future Performance

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
A logo

A: New Diagnostics And Lab Tools Pipeline Will Drive Future Upside Potential

Fair Value: US$174.9 17.2% undervalued intrinsic discount
32 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

0 Risks
4 Rewards
View Full Analysis

Agilent Technologies, Inc. Key Details

US$7.4b

Revenue

US$3.4b

Cost of Revenue

US$4.0b

Gross Profit

US$2.5b

Other Expenses

US$1.4b

Earnings

Last Reported Earnings
Jul 31, 2026
Next Reporting Earnings
n/a
5.11
53.65%
19.53%
53.6%
View Full Analysis

About A

Founded
1999
Employees
18200
CEO
Padraig McDonnell
WebsiteView website
www.agilent.com

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Recent A News & Updates

Recent updates

No updates

Agilent Technologies, Inc. Competitors

TMO logo

Thermo Fisher Scientific

Symbol: NYSE:TMO
Market cap: US$223.0b
AMGN logo

Amgen

Symbol: NasdaqGS:AMGN
Market cap: US$212.6b
GILD logo

Gilead Sciences

Symbol: NasdaqGS:GILD
Market cap: US$181.8b
PFE logo

Pfizer

Symbol: NYSE:PFE
Market cap: US$158.4b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide